Project Details
Short title | ROMAZA :A Phase I Trial of Romidepsin plus Azacitidine combination therapy in patients with Newly Diagnosed, Relapsed or Refractory Acute Myeloid Leukaemia Ineligible for Slavage Chemotherapy (ROMAZA) |
---|---|
Status | Finished |
Effective start/end date | 12/09/12 → 30/09/22 |
Funding
- CELGENE INTERNATIONAL SARL